期刊文献+

成人与少儿癫痫患者动态脑电图特征对照研究 被引量:3

A control study of dynamic EEG features of aduld and child epileptics
下载PDF
导出
摘要 目的探讨成人与少儿癫痫患者脑电图改变及痫样放电的特点。方法将≥18a的165例癫痫患者设为成人组,〈18a的199例癫痫患者设为少儿组,对两组患者进行24h动态脑电图描记分析,比较两组清醒期与睡眠期脑电图改变及痫样放电状况。结果成人组清醒期脑电图正常和痫样放电率均显著低于睡眠期(χ^2=7.648、12.725,P〈0.01),而非特异性异常率显著高于睡眠期(χ^2=60.789,P〈0.01)。少儿组清醒期脑电图正常率显著高于睡眠期(χ^2=4.513,P〈0.05),痫样放电率显著低于睡眠期(χ^2=7.705,P〈0.01)。成人组清醒期非特异性异常率、睡眠期正常率均显著高于少儿组(P〈0.01),而痫样放电率均显著低于少儿组(P〈0.01)。结论成人与少儿癫痫患者腩电图改变和痫样放电各有其特征。成人癫痫患者在睡眠期脑电图呈正常或出现痫样放电的两极分化。 Objective To explore the features of EEG changes and epileptiform discharges in aduld and child epileptics. Methods 165 epileptics aged 18 and older were assigned to adult group and 199 ones 〈 18 years to child group, 24 hour dynamic electroencephalography were conducted and analyzed in both groups, and EEG changes of both waking and sleep stage and epileptiform discharge status were compared between the 2 groups. Results In adult group,EEG normality and epileptiform discharge rate were significantly lower(χ^2= 7. 648,12. 725, P〈0.01) and non-specificity abnormality rate significantly higher(χ^2=60. 789,P〈0.01) at waking than at sleep stage. In child group, EEG normality rate was significantly higher (χ^2= 4.513, P〈 0.05 ) and epileptiform discharge rate significantly lower (χ^2= 7. 705, P 〈 0.01 ) at waking than at sleep stage. Non-specificity abnormality rate at waking stage and EEG normality rate at sleep stage were significantly higher(P〈0.01) and epileptiform discharge rate significantly lower (P 0.01) in adult than in child group. Conclusion EEG changes and epileptiform discharges of adult and child epileptics have own features. At sleep stage, adult epileptics exhibit polarization of normal EEGs or epileptiform discharges.
出处 《临床心身疾病杂志》 CAS 2009年第6期514-515,共2页 Journal of Clinical Psychosomatic Diseases
关键词 癫痫 动态脑电图 成人 少儿 痫样放电 Epilepsy dynamic EEG adult child epileptiform discharge
  • 相关文献

参考文献6

二级参考文献15

共引文献11

同被引文献29

  • 1Engel J Jr, ILAE. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report o{ ILAE Task Force on Classification and Terminology [J]. Epilepsia, 2001, 42(6) : 769. 被引量:1
  • 2Nakamura J, Kuwana Y, Yukitoshi-N. Target pharma-cology of topiramate, a new antiepileptic drug [J]. Nihon Yakurigaku Zasshi, 2000, 115(1) : 53. 被引量:1
  • 3Shank RP, Gardocki JF, Streeter AJ, et al. An over- view of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action [J]. Epilepsia, 2000, 41(Suppl 1): $3. 被引量:1
  • 4Stephen LJ, Sills GJ, Brodie MJ. Topiramate in refrac- tory epilepsy: a prospective observational study [J]. Epilep- sia, 2000, 41(8) 977. 被引量:1
  • 5Mohamed K, Appleton R, Rosenbloom L. Efficacy and tolerability of topiramate in childhood and adolescent epilep- sy.- a clinical experience [J]. Seizure, 2000, 9(2): 137. 被引量:1
  • 6Glauser TA, Clark PO, McGee K. Long-term response to topiramate in patients with West syndrome [J]. Epilep- sia, 2000, 41(Suppl 1) $91. 被引量:1
  • 7Abou-Khalil B. Topiramate in the long-term manage- ment of refractory epilepsy. Topiramate YOL Study Group [J]. Epilepsia, 2000, 41(Suppl 1).. $72. 被引量:1
  • 8Tassinari CA, Micheluddi R, Chaurel P, et al. Double- blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy [J]. Epilep-sia, 1996, 37(8): 763. 被引量:1
  • 9Ben-Menachem E, Henreksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add- on therapy in patients with refractory partial seizures [J]. Epilepsia, 1996, 37(6): 539. 被引量:1
  • 10Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo controlled dose-ranging trial in refractory partial epi- lepsy using 200-, 400-, and 600-mg daily dosages. Topira- mate YD Study Group [J]. Neurology, 1996, 46(6) .. 1684. 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部